Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review
- PMID: 11792458
- DOI: 10.1016/s0197-0186(01)00095-x
Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review
Abstract
Molecular water pumps (MWPs) are characterized as biochemical systems existing at a compartmental boundary of living cells that can actively pump water against its gradient. A role for the observed intercompartmental transport of N-acetyl-L-aspartate (NAA), between neurons and oligodendrocytes in the CNS, as an efflux MWP for the removal of neuronal metabolic water has been proposed. In this review, accumulating evidence in support of such a role for NAA is presented, and the dynamics of the NAA cycle in myelinated neurons are considered. Based on the results of recent investigations, it is calculated that 1 mol of NAA is synthesized for every 40 mol of glucose (Glc) equivalent oxidized in the brain, and each mol of NAA may transport 121 mol of metabolic water out of neurons. In addition, turnover of total brain NAA is very rapid and appears to be only 16.7 h. Thus, the most important characteristic of NAA in the brain may not be its static level, but a dynamic aspect related to its rapid turnover. The relationship of NAA as a potential MWP to Canavan disease (CD), a genetic spongiform leukodystrophy in which the catabolic portion of the NAA cycle is deficient, and in a newly recognized brain disorder, hypoacetylaspartia, where the anabolic portion of the NAA cycle appears to be deficient, are discussed.
Similar articles
-
N-acetylaspartate in the vertebrate brain: metabolism and function.Neurochem Res. 2003 Jun;28(6):941-53. doi: 10.1023/a:1023250721185. Neurochem Res. 2003. PMID: 12718449 Review.
-
Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation.J Mol Neurosci. 2003;21(3):185-90. doi: 10.1385/jmn:21:3:185. J Mol Neurosci. 2003. PMID: 14645985 Review.
-
Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.J Mol Neurosci. 1999 Aug-Oct;13(1-2):47-53. doi: 10.1385/JMN:13:1-2:47. J Mol Neurosci. 1999. PMID: 10691291
-
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.Acta Neuropathol. 2018 Jan;135(1):95-113. doi: 10.1007/s00401-017-1784-9. Epub 2017 Nov 7. Acta Neuropathol. 2018. PMID: 29116375 Free PMC article.
-
Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.J Mol Neurosci. 1997 Oct;9(2):109-25. doi: 10.1007/BF02736855. J Mol Neurosci. 1997. PMID: 9407392 Review.
Cited by
-
N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.Prog Neurobiol. 2007 Feb;81(2):89-131. doi: 10.1016/j.pneurobio.2006.12.003. Epub 2007 Jan 5. Prog Neurobiol. 2007. PMID: 17275978 Free PMC article. Review.
-
Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.PLoS One. 2010 Apr 22;5(4):e10293. doi: 10.1371/journal.pone.0010293. PLoS One. 2010. PMID: 20421982 Free PMC article.
-
Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair.Front Cell Neurosci. 2021 Apr 23;15:661928. doi: 10.3389/fncel.2021.661928. eCollection 2021. Front Cell Neurosci. 2021. PMID: 33967698 Free PMC article. Review.
-
Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema.J Neurosci. 2005 Aug 10;25(32):7352-8. doi: 10.1523/JNEUROSCI.1002-05.2005. J Neurosci. 2005. PMID: 16093385 Free PMC article.
-
Miniature pig magnetic resonance spectroscopy model of normal adolescent brain development.J Neurosci Methods. 2018 Oct 1;308:173-182. doi: 10.1016/j.jneumeth.2018.08.008. Epub 2018 Aug 9. J Neurosci Methods. 2018. PMID: 30099002 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources